EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Anti‐Prion Systems in Saccharomyces cerevisiae

Reed B Wickner iD, Yuho Hayashi, Herman K Edskes

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.70045 ↗

At a glance

Übersichtsarbeit in Journal of Neurochemistry, 2025. Written by Reed B Wickner and 2 co-authors. Institution: Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, M…. Major MEDLINE topics: Saccharomyces cerevisiae, Prions, Saccharomyces cerevisiae Proteins. Cited 4 times so far (Crossref); 187 references. The full text is freely available (open access, CC BY 4.0). Funded by: Intramural NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

[PSI+] is a prion (infectious protein) of Sup35p, a subunit of the translation termination factor, and [URE3] is a prion of Ure2p, a mediator of nitrogen catabolite repression. Here, we trace the history of these prions and describe the array of anti‐prion systems in S. cerevisiae . These systems work together to block prion infection, prion generation, prion propagation, prion segregation, and the lethal (and near‐lethal) effects of most variants of these prions. Each system lowers the appearance of prions 2‐ to 15‐fold, but together, ribosome‐associated chaperones, the Hsp104 disaggregase, and the Sup35p‐binding Upf proteins lower the frequency of [PSI+] appearance by ~5000‐fold. [PSI+] variants can be categorized by their sensitivity to the various anti‐prion systems, with the majority of prion isolates sensitive to all three of the above‐mentioned systems. Yeast prions have been used to screen for human anti‐prion proteins, and five of the Bag protein family members each have such activity. We suggest that manipulation of human anti‐prion systems may be useful in preventing or treating some of the many human amyloidoses currently found to be prions with the same amyloid architecture as the yeast prions. image

Subjects

MeSH terms (MEDLINE)

Saccharomyces cerevisiaePrionsSaccharomyces cerevisiae ProteinsHumansPeptide Termination FactorsMolecular Chaperones

Author keywords

Btn2Cur1Hsp104Upf proteinsinositol polyphosphatesribosome‐associated chaperones

Substances

PrionsSaccharomyces cerevisiae ProteinsPeptide Termination FactorsMolecular Chaperones

Authors and institutions

  • Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

ORCID profiles: Reed B Wickner

Funding

  • Intramural NIH HHS
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Cite

APA

Wickner, R. B., Hayashi, Y., & Edskes, H. K. (2025). Anti‐Prion Systems in Saccharomyces cerevisiae. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70045

Vancouver

Wickner RB, Hayashi Y, Edskes HK. Anti‐Prion Systems in Saccharomyces cerevisiae. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70045

BibTeX
@article{Wickner2025,
  author = {Wickner, Reed B and Hayashi, Yuho and Edskes, Herman K},
  title = {Anti‐Prion Systems in Saccharomyces cerevisiae},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.70045}
}
Start for free →